Showing results (161-170 of 295) with videos related to

Sort By:
Pageof 30
Pulmonary Circulation|January 11, 2024
Pulmonary hypertension in the setting of interstitial lung disease: Approach to management and treatment. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative-Group 3 Pulmonary HypertensionOksana A Shlobin, Eric Shen, Stephen J Wort, et al.
American Journal of Respiratory and Critical Care Medicine|November 12, 2021
Efficacy of Inhaled Treprostinil on Multiple Disease Progression Events in Patients with Pulmonary Hypertension due to Parenchymal Lung Disease in the INCREASE TrialSteven D Nathan, Victor F Tapson, Jean Elwing, et al.
Chest|July 7, 2011
Long-term course and prognosis of idiopathic pulmonary fibrosis in the new millenniumSteven D Nathan, Oksana A Shlobin, Nargues Weir, et al.
Pulmonary Circulation|June 21, 2024
Excess healthcare resource utilization and costs for commercially insured patients with pulmonary arterial hypertension: A real-world data analysisTracey Weiss, Dena R Ramey, Ngan Pham, et al.
Respiratory Medicine|March 13, 2013
Effect of aerobic exercise training on fatigue and physical activity in patients with pulmonary arterial hypertensionAli A Weinstein, Lisa M K Chin, Randall E Keyser, et al.
Chest|May 19, 2026
Evolving Concepts in Pulmonary Hypertension: Implementation challenges of the current guidelines and proceedings in the USSandeep Sahay, Rodolfo A Estrada, Megan Griffiths, et al.
Therapeutic Advances in Respiratory Disease|October 30, 2020
HRCT evaluation of patients with interstitial lung disease: comparison of the 2018 and 2011 diagnostic guidelinesSteven D Nathan, Jean Pastre, Inga Ksovreli, et al.
Chest|May 11, 2020
A 48-Year-Old South African Woman with Rheumatoid Arthritis and Lung NodulesMatthew Koslow, Sami M Bennji, Stephanie Griffith-Richards, et al.
The Lancet. Respiratory Medicine|August 17, 2023
Pulmonary hypertension associated with lung disease: new insights into pathomechanisms, diagnosis, and managementKaren M Olsson, Tamera J Corte, Jan C Kamp, et al.
BMJ Open Respiratory Research|July 5, 2022
Study design and rationale for the TETON phase 3, randomised, controlled clinical trials of inhaled treprostinil in the treatment of idiopathic pulmonary fibrosisSteven D Nathan, Jurgen Behr, Vincent Cottin, et al.
Pageof 30